Return to revision history
Revision as of 21:02:14, 5 November 2022 by 3.221.77.51
Revision as of 6:11:41, 10 November 2022 by 3.221.77.51
Line 1: Line 1:
According to the National Cancer Institute, for breast cancer, the five year survival rate <a href=https://nolvadex.one/>tamoxifen warnings</a>
<a href=https://priligy.me/>buy priligy cheap</a> For patients treated with 3 or more prior chemotherapy regimens and whose cancer is associated with homologous recombination deficient HRD positive status defined by either 1 a deleterious or suspected deleterious BRCA mutation; or 2 genomic instability and progression 6months after response to the last platinum based chemotherapy